TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

INWOOD LABS

CardiovascularNeurologyGastroenterology
Generics

INWOOD LABS is a generic drug manufacturer focused on Cardiovascular, Neurology, Gastroenterology.

1971
Since
14
Drugs
-
Trials
173
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

PROPRANOLOL HYDROCHLORIDE 2026-01-27
CARBAMAZEPINE 2026-01-05
Labeling
PREDNISONE 2025-10-01
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE 2025-09-19
Manufacturing (CMC)
CARBAMAZEPINE 2025-08-15
Labeling
CARBAMAZEPINE 2025-07-25
METHYLTESTOSTERONE 2025-07-11
Labeling
METHYLTESTOSTERONE 2025-07-11
Labeling
METHYLTESTOSTERONE 2025-07-11
Labeling
METHYLTESTOSTERONE 2025-07-11
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 40%
2 drugs
Neurology 40%
2 drugs
Gastroenterology 20%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology, Neurology
WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology
Bristol-Myers Squibb big-pharma
Gastroenterology, Neurology
BAUSCH specialty
Cardiovascular, Gastroenterology
Takeda big-pharma
Gastroenterology, Neurology